Footnotes
ID | footnote |
f1 |
the sales reported in this form 4 were effected pursuant to a 10b5-1 trading plan adopted by mr. vohra on november 16, 2022. |
f2 |
the price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $137.60 to $138.43. the reporting person hereby undertakes, upon request of the staff of the u.s. securities and exchange commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
f3 |
the price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $138.82 to $139.32. the reporting person hereby undertakes, upon request of the staff of the u.s. securities and exchange commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
f4 |
the price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $138.03 to $138.81. the reporting person hereby undertakes, upon request of the staff of the u.s. securities and exchange commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
f5 |
the price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $139.07 to $139.49. the reporting person hereby undertakes, upon request of the staff of the u.s. securities and exchange commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
f6 |
this option became exercisable in three equal annual installments beginning on march 4, 2017, which was the first anniversary of the date on which the option was granted. |